A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Conditions: Prostatic Neoplasms Interventions: Drug: Novel hormonal therapy Sponsors: Pfizer; Astellas Pharma Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Learning | Pfizer | Pharmaceuticals | Prostate Cancer | Research | Study | Universities & Medical Training